
\begin{tabular}[t]{llll}
\toprule
Â  & CDK4/6i & HT & Overall\\
\midrule
 & (N=228) & (N=43) & (N=271)\\
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{Age at treatment start}}\\
\hspace{1em}Mean (SD) & 59.1 (11.5) & 60.1 (12.4) & 59.3 (11.6)\\
\hspace{1em}Median [Min, Max] & 59.0 [28.0, 84.0] & 62.0 [34.0, 85.0] & 60.0 [28.0, 85.0]\\
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{Drug}}\\
\hspace{1em}Anastrozol & 0 (0\%) & 3 (7.0\%) & 3 (1.1\%)\\
\hspace{1em}Exemestane & 0 (0\%) & 4 (9.3\%) & 4 (1.5\%)\\
\hspace{1em}Fulvestrant & 0 (0\%) & 5 (11.6\%) & 5 (1.8\%)\\
\hspace{1em}Letrozol & 0 (0\%) & 31 (72.1\%) & 31 (11.4\%)\\
\hspace{1em}Palbociclib & 127 (55.7\%) & 0 (0\%) & 127 (46.9\%)\\
\hspace{1em}Ribociclib & 98 (43.0\%) & 0 (0\%) & 98 (36.2\%)\\
\hspace{1em}Missing & 3 (1.3\%) & 0 (0\%) & 3 (1.1\%)\\
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{Estrogen Receptor}}\\
\hspace{1em}+ & 228 (100\%) & 42 (97.7\%) & 270 (99.6\%)\\
\hspace{1em}- & 0 (0\%) & 1 (2.3\%) & 1 (0.4\%)\\
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{Progesterone Receptor}}\\
\hspace{1em}+ & 171 (75.0\%) & 27 (62.8\%) & 198 (73.1\%)\\
\hspace{1em}- & 57 (25.0\%) & 16 (37.2\%) & 73 (26.9\%)\\
\addlinespace[0.3em]
\multicolumn{4}{l}{\textbf{Stage}}\\
\hspace{1em}I & 17 (7.5\%) & 3 (7.0\%) & 20 (7.4\%)\\
\hspace{1em}II & 55 (24.1\%) & 20 (46.5\%) & 75 (27.7\%)\\
\hspace{1em}III & 63 (27.6\%) & 11 (25.6\%) & 74 (27.3\%)\\
\hspace{1em}IV & 76 (33.3\%) & 2 (4.7\%) & 78 (28.8\%)\\
\hspace{1em}Missing & 17 (7.5\%) & 7 (16.3\%) & 24 (8.9\%)\\
\bottomrule
\end{tabular}
